Faculty Directory
- Name
- Kim, Sun Mi
- Faculty Appointment
(title, department)
-
Research Professor, Department of Cancer Biomedical Science, NCC-GCSP
- Area of Expertise
- Cancer Biology, Stem Cell Biology
- Contact no
- +82-31-920-2265
- E-mail
- ksm999@ncc.re.kr
- Work Experience
-
2013.01~ The Research Institute of National Cancer Center
- Educational Background
-
B.S., Pusan National University (1999.03~2003.02)
M.S., The Graduate School of Pusan National University (2003.03~2005.02)
Ph.D., The Graduate School, Yonsei University
(2008.09~2012.02)
- Research Interests
-
Cancer Biology, Stem Cell Biology, Molecular Biology
- Achievements
-
Bae JS, Kim SM, Jeon Y, Sim J, Jang JY, Son J, Hong W, Park MK, Lee H. Loss of Mob1a/b impairs the differentiation of mouse embryonic stem cells into the three germ layer lineages. Exp Mol Med. 2019 Nov 14;51(11):1-12. (IF 8.718)
Jeon Y, Park MK, Kim SM, Bae JS, Lee CW, Lee H. TopBP1 deficiency impairs the localization of proteins involved early recombination and results in meiotic chromosome defects during spermatogenesis. Biochem Biophys Res Commun. 2019 Jan 15;508(3):722-728. (IF 3.575)
Bae JS, Jeon Y, Kim SM, Jang JY, Park MK, Kim IH, Hwang DS, Lim DS, Lee H. Depletion of MOB1A/B causes intestinal epithelial degeneration by suppressing Wnt activity and activating BMP/TGF-β signaling. Cell Death Dis. 2018 Obt 22;9(11):1083. (IF 8.469)
Kim D, Kim S, Oh Y, Park S, Jeon Y, Kim H, Lee H, Kim S. AIMP3 depletion induces acute radiation syndrome-like phenotype in Mice. Sci Rep. 2018 Oct 9;8(1):15025. (IF 4.379)
Kim SM, Jeon Y, Kim D, Jang H, Bae JS, Park MK, Kim H, Kim S, Lee H. AIMP3 depletion causes genome instability and loss of stemness in mouse embryonic stem cells. Cell Death Dis. 2018 Sep 24;9(10):972. (IF 8.469)
Bae JS, Kim SM, Lee H. The hippo signaling pathway provides novel-anti-cancer drug targets. Oncotarget. 2017 Feb 28;8(9):16084-16098.
Kim SM, Yun MR, Hong YK, Solca F, Kim JH, Kim HJ, Cho BC. Glycolysis inhibition sensitizes non-small cell lung cancer with T790M mutation to irreversible EGFR inhibitors via translational suppression of Mcl-1 by AMPK activation. Mol Cancer Ther. 2013 Oct;12(10):2145-56. (IF 6.261)
Kim HR, Ahn JR, Lee JG, Bang DH, Ha SJ, Hong YK, Kim SM, Nam KC, Rha SY, Soo RA, Riely GJ, Kim JH, Cho BC. The impact of cigarette smoking on the frequency of and qualitative differences in KRAS mutations in Korean patients with lung adenocarcinoma. Yonsei Med J. 2013 Jul;54(4):865-74. (IF 2.759)
Kim SH, Shim HS, Cho J, Jeong JH, Kim SM, Hong YK, Sung JH, Ha SJ, Kim HR, Chang H, Kim JH, Tania C, Cho BC. A phase I trial of gefitinib and nimotuzumab in patients with advanced non-small cell lung cancer (NSCLC). Lung Cancer. 2013 Mar;79(3):270-5. (IF 5.705)
Kim SM, Kwon OJ, Hong YK, Kim JH, Solca F, Ha SJ, Soo RA, Christensen JG, Lee JH, Cho BC. Activation of IL-6R/JAK1/STAT3 signaling induces de novo resistance to irreversible EGFR inhibitors in non-small cell lung cancer with T790M resistance mutation. Mol Cancer Ther. 2012 Oct;11(10):2254-64. (IF 6.261)
Kim HS, Kim HR, Kim GM, Kim HS, Koh YW, Kim SH, Choi EC, Hong YK, Sung JH, Kim SM, Kim JH, Cho BC. The efficacy and toxicity of S-1 and cisplatin as first-line chemotherapy in recurrent or metastatic head and neck squamous cell carcinoma. Cancer Chemother Pharmacol. 2012 Oct;70(4):539-46. (IF 3.333)
Kim GM, Kim YS, Ae Kang Y, Jeong JH, Kim SM, Hong YK, Sung JH, Lim ST, Kim JH, Kim SK, Cho BC. Efficacy and toxicity of belotecan for relapsed or refractory small cell lung cancer patients. J Thorac Oncol. 2012 Apr;7(4):731-6. (IF 15.609)
Kim SM, Kim JS, Kim JH, Yun CO, Kim EM, Kim HK, Solca F, Choi SY, Cho BC. Acquired resistance to cetuximab is mediated by increased PTEN instability and leads cross-resistance to gefitinib in HCC827 NSCLC cells. Cancer Lett. 2010 Oct 28;296(2):150-9. (IF 8.679)
Kim CH, Ko AR, Lee SY, Jeon HM, Kim SM, Park HG, Han SI, Kang HS. Hypoxia switches glucose depletion-induced necrosis to phosphoinositide-3 kinase/Akt-dependent apoptosis in A549 lung adenocarcinoma cells. Int J Oncol. 2010 Jan;36(1):117-24. (IF 5.650)
Oh SY, Kim JH, Park MJ, Kim SM, Yoon CS, Joo YM, Park JS, Han SI, Park HG, Kang HS. Induction of heat shock protein 72 in C6 glioma cells by methyl jasmonate through ROS-dependent heat shock factor 1 activation. Int J Mol Med. 2005 Nov;16(5):833-9. (IF 4.101)
Seo MS, Oh SY, Park MJ, Kim SM, Kim MY, Han SI, Park HG, Kang HS. Implication of reactive oxygen species, ERK1/2, and p38MAPK in sodium salicylate-induced heat shock protein 72 expression in C6 glioma cells. Int J Mol Med. 2005 Nov;16(5):841-9. (IF 4.101)
